Categories: Business

ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders

NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Elevation Oncology, Inc. (NASDAQ: ELEV) to Concentra Biosciences, LLC is fair to Elevation shareholders. Under the terms of the proposed transaction, Elevation shareholders will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% of any net proceeds received within five years following closing from any disposition of EO-1022 that occurs within one year following closing.

- Advertisement -


- Advertisement -

Halper Sadeh encourages Elevation shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

- Advertisement -

The investigation concerns whether Elevation and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Elevation shareholders; (2) determine whether Concentra is underpaying for Elevation; and (3) disclose all material information necessary for Elevation shareholders to adequately assess and value the merger consideration.

- Advertisement -

On behalf of Elevation shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

- Advertisement -

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

- Advertisement -

Attorney Advertising. Prior results do not guarantee a similar outcome.

- Advertisement -

Contacts

- Advertisement -

Halper Sadeh LLC

One World Trade Center

85th Floor

New York, NY 10007

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

- Advertisement -
Business Wire

Recent Posts

AN ICON HEADS TO THE LONE STAR STATE: ROYAL CARIBBEAN ANNOUNCES BOLD 2027-28 VACATIONS FROM TEXAS, CALIFORNIA AND THE NORTHEAST

The vacation brand is ramping up on memory-making with adventure-filled lineups, including the world's best…

1 hour ago

NYSE Content Advisory: Pre-Market Update + Delta Air Lines Marks 100 Years

NEW YORK, Nov. 12, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…

1 hour ago

Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq

FORT PIERCE, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or…

3 hours ago

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting

November 12, 2025 18:03 ET  | Source: Aurora Spine Corporation Company to Showcase Cutting-Edge Innovations…

3 hours ago

Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results

CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc.…

5 hours ago

Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

Khing Oei appointed Chairman of the Board; Will McEvoy appointed Chief Investment Officer and Member…

5 hours ago